Samsara BioCapital

Samsara BioCapital

Pulse 2.0

Allakos (ALLK) Stock: Why It Surged 21.73% Today

Pulse 2.0

Chinook Therapeutics (KDNY) Stock: Why It Increased 4.57% Today

Pulse 2.0

Sutro Biopharma (STRO) Stock: Why It Surged Over 19% Today

Pulse 2.0

Atreca (BCEL) Stock: Why The Price Is Much Higher Today

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell Today

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Increased Today

Pulse 2.0

Allakos Stock (ALLK): Why The Price Substantially Dropped Today

GeekWire

Chinook Therapeutics helps form China-based biotech venture to treat kidney disease

$78,000,000 Venture capital (Series B)
MedCity News

Exo Therapeutics adds $78M as cancer, inflammation drugs march toward clinic

neurons.AI

Utah AI/biotech innovator Recursion Pharmaceuticals on a roll, doubling downtown HQ

neurons.AI

Best in Tech Awards 2021: Delfi Diagnostics

TechCrunch

ElevateBio raises $525M to advance its cell and gene therapy technologies

$85,000,000 Venture capital (Series A)
GeekWire

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location

$100,000,000 Venture capital (Series A)
neurons.AI

Delfi Diagnostics Nets $100M in Series A Financing, Plans Multi-Cancer Screening Test

neurons.AI

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early …

$71,500,000 Venture capital (Series B)
FinSMEs

A2 Biotherapeutics Closes $71.5M Series B Funding

$100,000,000 Undisclosed
FinSMEs

Flame Biosciences Completes $100M Common Stock Financing

$239,000,000 Venture capital (Series D)
FinSMEs

Recursion Raises $239M in Series D Equity Financing

Forbes Tech

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery